Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Koopman

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
Clinical Colorectal Cancer|November 22, 2017
Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer GroupLotte Keikes, Martijn G H van Oijen, Valery E P P Lemmens, et al.
Cell Reports|November 30, 2022
BRAF<sup>V600E</sup> in colorectal cancer reduces sensitivity to oxidative stress and promotes site-specific metastasis by stimulating glutathione synthesisJamila Laoukili, Susanne van Schelven, Emre Küçükköse, et al.
Anticancer Research|July 31, 2020
Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based StudyLotte Keikes, Miriam Koopman, Valery E P P Lemmens, et al.
Cells|December 18, 2020
Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal CancerAfroditi Nanou, Linda Mol, Frank A W Coumans, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2009
Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO studyMiriam Koopman, Sabine Venderbosch, Harm van Tinteren, et al.
Pharmacogenomics|November 28, 2013
Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samplesLieke van Huis-Tanja, Dinemarie Kweekel, Hans Gelderblom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2020
Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling FrameworkIda Netterberg, Mats O Karlsson, Leon W M M Terstappen, et al.
Cancer Epidemiology|December 11, 2024
The nationwide Dietary Intake after Diagnosis and Colorectal Cancer Outcomes (PLCRC-PROTECT) cohort: Study design, clinical characteristics and baseline health behaviorsJeroen W G Derksen, Karel C Smit, Irene W F Hoeven, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2017
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer GroupJohannes J M Kwakman, Lieke H J Simkens, Linda Mol, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Comparing Modeling Approaches for Discrete Event Simulations With Competing Risks Based on Censored Individual Patient Data: A Simulation Study and Illustration in Colorectal CancerKoen Degeling, Maarten J IJzerman, Catharina G M Groothuis-Oudshoorn, et al.
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
Clinical Colorectal Cancer|November 22, 2017
Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer GroupLotte Keikes, Martijn G H van Oijen, Valery E P P Lemmens, et al.
Cell Reports|November 30, 2022
BRAF<sup>V600E</sup> in colorectal cancer reduces sensitivity to oxidative stress and promotes site-specific metastasis by stimulating glutathione synthesisJamila Laoukili, Susanne van Schelven, Emre Küçükköse, et al.
Anticancer Research|July 31, 2020
Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based StudyLotte Keikes, Miriam Koopman, Valery E P P Lemmens, et al.
Cells|December 18, 2020
Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal CancerAfroditi Nanou, Linda Mol, Frank A W Coumans, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2009
Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO studyMiriam Koopman, Sabine Venderbosch, Harm van Tinteren, et al.
Pharmacogenomics|November 28, 2013
Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samplesLieke van Huis-Tanja, Dinemarie Kweekel, Hans Gelderblom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2020
Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling FrameworkIda Netterberg, Mats O Karlsson, Leon W M M Terstappen, et al.
Cancer Epidemiology|December 11, 2024
The nationwide Dietary Intake after Diagnosis and Colorectal Cancer Outcomes (PLCRC-PROTECT) cohort: Study design, clinical characteristics and baseline health behaviorsJeroen W G Derksen, Karel C Smit, Irene W F Hoeven, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2017
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer GroupJohannes J M Kwakman, Lieke H J Simkens, Linda Mol, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Comparing Modeling Approaches for Discrete Event Simulations With Competing Risks Based on Censored Individual Patient Data: A Simulation Study and Illustration in Colorectal CancerKoen Degeling, Maarten J IJzerman, Catharina G M Groothuis-Oudshoorn, et al.
Pageof 20